Atlas Trials

Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and Cytarabine

Clinical trial NCT00503594 · UNKNOWN

Trial details

NCT number
NCT00503594
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2007-07-01
Primary completion
2010-07-01
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.